Retinal Blood Flow Autoregulation as an Early Biomarker for Glaucoma

Overview

A University of Maryland study presented at the 2026 American Glaucoma Society meeting found that impaired retinal blood flow autoregulation occurs in early glaucoma before structural damage or vision loss is detectable. Dynamic vascular reactivity measures differentiated control eyes from preperimetric glaucoma suspects and mild primary open-angle glaucoma patients, suggesting potential for earlier disease detection.

Background

Glaucoma progression often continues despite well-controlled intraocular pressure, highlighting the need for additional biomarkers beyond traditional IOP monitoring. Prior epidemiologic studies have linked systemic hemodynamic factors to glaucoma risk, implicating vascular dysregulation in disease pathophysiology. Retinal blood flow autoregulation, the ability of ocular vessels to adapt to metabolic demands, remains an underexplored feature that may precede structural optic nerve damage. The University of Maryland team investigated this by assessing optic nerve head blood flow responses to hyperoxia in glaucoma and control patients.

Data Highlights

Key Findings

• Baseline optic nerve head blood flow was highest in controls and lowest in mild POAG patients.
• Under induced hyperoxia, controls and glaucoma suspects showed >10% decrease in blood flow, indicating normal vascular reactivity.
• Mild POAG eyes exhibited a smaller decrease in blood flow under hyperoxia, suggesting impaired autoregulation.
• Secondary indices such as resistivity index and volumetric skew showed greater dynamic changes in controls versus glaucoma patients.
• Some glaucoma suspects displayed autoregulatory patterns closer to early glaucoma than controls, indicating early vascular changes before visual field loss.
• Findings support retinal blood flow autoregulation as a potential early biomarker supplementing structural and functional glaucoma assessments.

Clinical Implications

Measuring retinal blood flow autoregulation could enhance early glaucoma detection, especially in patients without detectable structural or functional damage. This vascular biomarker may identify patients at risk of progression despite controlled intraocular pressure, enabling earlier intervention. Incorporating dynamic blood flow assessments could complement existing diagnostic tools like OCT and perimetry.

Conclusion

Impaired retinal blood flow autoregulation precedes structural optic nerve damage in glaucoma, offering a promising physiological marker for early disease detection. Further research may establish its role in clinical glaucoma management to improve patient outcomes.

References

1. Leske MC et al. 1994 -- The Barbados Eye Study: Prevalence of open angle glaucoma
2. Sommer A et al. 1991 -- Relationship between intraocular pressure and primary open-angle glaucoma: the Baltimore Eye Survey
3. Tielsch JM et al. 1995 -- Hypertension, perfusion pressure, and primary open-angle glaucoma
4. Vinnett A et al. 2022 -- Dynamic alterations in blood flow in glaucoma measured with laser speckle contrast imaging
5. Quigley HA, Addicks EM. 1981 -- Regional differences in the structure of the lamina cribrosa and glaucomatous optic nerve damage